The paper presents the development, assessment of the safety and antiradiation activity of a therapeutic agent based on the culture of Escherichia coli strains “PL-6” and “KV-1”. To obtain the antiradiation agent, the causative agent of colibacillosis was grown in meat-peptone broth in a thermostat at a temperature of 37°C for 3 days. The grown suspension was centrifuged at 3000 rpm for 50 min, the supernatant was decanted. The sediment was brought to 1 billion cm3 with distilled water. Smears were prepared from the grown cultures and stained according to Gram to determine the purity and species of the grown culture. The prepared suspension was poured into sterile vials of 10, 50 or 100 cm3, sealed with rubber stoppers and rolled with aluminum caps, labeling with an indication of the strain, radiation dose and date. Irradiation of the microbial material was carried out on the γ-installation “Issledovatel”, source 60Co, absorbed dose rate of 1.028 Gy/sec, in the ranges of absorbed doses from 7.5 to 30.0 kGy with interdose intervals of 2.5 and 5.0 kGy. The degree of inactivation of γ-irradiated E. coli cultures was determined by seeding them on meat-peptone agar and thermostatting for 168 hours, recording the presence or absence of microorganism growth. The studies have established that the timing and degree of growth of irradiated E. coli cultures of the “PL-6” and “KV-1” strains are directly dependent on the radiation dose, their complete inactivation occurs with irradiation at a dose of 25.0 kGy. Further studies have shown that the developed biopreparation obtained on the basis of E. coli is sterile, areactogenic, non-toxic and harmless. The mechanism of formation of radioresistance of the organism against the background of application of antiradiation agents based on E. coli strains “PL-6” and “KV-1” consisted in restoration of hematological, biochemical and immune parameters, which contributed to preservation of 66.7 to 83.3٪ of lethally irradiated animals.
The paper presents the results of evaluating the therapeutic effectiveness of a composition based on anti-radiation serum and metabolic products of bifidobacteria on laboratory animals subjected to experimental combined radiation and thermal effects. 124 mongrel white rats of both sexes with a live weight of 180–220 g were used as a biological model in the work. The simulation of radiation damage to the body was carried out by a single external irradiation of animals on a Puma gamma installation with a 137Cs radiation source with an exposure dose of 8.5×10–2 A/kg in an absorbed dose of 7.5 Gy. Thermal injury was inflicted by applying a brass plate heated to 200°C with an area of 4.9 cm2 with a retention exposure of 8 seconds to the trimmed area of the upper third of the thigh, inducing a grade III burn. The effectiveness of the therapeutic drug was evaluated according to the following criteria: changes in the titer of the compliment, the concentration of radiotoxin and thermotoxin, changes in the methodological parameters of peripheral blood, the degree of burn damage, survival and life expectancy of fallen animals. The results of tests evaluating the therapeutic effectiveness of the tested composition showed that a single subcutaneous injection of a medicinal product at a dose of 20 mg/kg followed by application of an anti-burn ointment based on bee podmore and St. John’s wort oil at intervals of 24, 48 and 168 hours accelerated the formation of a burn scab by 1.75 times (p 0.01), complete rejection of the burn scab — by 1.15 times (p 0.05), the complete healing of the burn wound accelerated by 1.18 times compared with the control groups, thereby increasing the survival rate to 87.5% (p 0.05) of animals exposed to two-factor exposure to the affected factors, while increasing the average life expectancy to 28.0 days versus 6.5 days in the control (irradiation + burn).
1 March 2021 in IOP Conference Series: Earth and Environmental Science
Environmental pollution with ecotoxicants makes humanity rethink its attitude to the world around it and accept the concept of the need to protect people and animals living on our planet. This paper presents the results of experimental studies of substances of natural origin for the selection of the most promising ones in order to create a multifunctional means of protecting farm animals in areas of anthropogenic pollution. In vitro experiments on lethally irradiated lymphocytes of the peripheral blood of animals, the radioprotective properties of phytogenic preparations were evaluated, and a three-component radioprotective composition was created. On lethally irradiated laboratory animals, the radioprotective activity of various compositions constructed from microbial biomasses and metabolic products of E. coli “PL-6”, B. bifidum 1 bacterial strains, phyto- and zoo drugs preparations radiomodified at a dose of 4 kGy was tested. From the metabolites of the radiomodified bacterial strain B. bifidum 1 (R6), the phytopreparation “Turmeric” and the biologically active feed additive “Vita-Force M”, the phytozoic microbial preparation FZMP was designed and tested on laboratory animals, which provided protection from radiation death to 80% of lethally irradiated laboratory animals, with 100% death of rats in the irradiation control group.
The results of evaluating the therapeutic effectiveness of a composition based on antiradiation serum and metabolic products of bifidobacteria on laboratory animals subjected to experimental combined radiation and thermal effects are presented. In this work 124 mongrel white rats of both sexes with a live weight of 180–220 g were used as a biological model. The simulation of radiation damage to the body was carried out by a single external irradiation of animals on a Puma gamma installation with a 137Cs radiation source with an exposure dose of 8.5 × 10–2 A/kg in an absorbed dose of 7.5 Gy. Thermal injury was inflicted by applying a brass plate heated to 200°C with an area of 4.9 cm2 with a retention exposure of eight seconds to the trimmed area of the upper third of the thigh, inducing a grade III burn. The effectiveness of the therapeutic drug was evaluated according to the following criteria: changes in the titer of the compliment, the concentration of radiotoxin and thermotoxin, changes in the methodological parameters of the peripheral blood, the degree of burn damage, survival, and life expectancy of fallen animals. The results of tests evaluating the therapeutic effectiveness of the tested composition showed that a single subcutaneous injection of a medicinal product at a dose of 20 mg/kg followed by application of an anti-burn ointment based on bee podmore and St. John’s wort oil at intervals of 24, 48, and 168 h accelerated the formation of a burn scab by 1.75 times (p < 0.01), complete rejection of the burn scab increased by 1.15 times (p < 0.05), and the complete healing of the burn wound accelerated by 1.18 times compared with the control groups, thereby increasing the survival rate to 87.5% (p < 0.05) of animals exposed to two-factor exposure to the affected factors, while increasing the average life expectancy to 28.0 days versus 6.5 days in the control (irradiation + burn).